| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Mauna Kea Technologies: Publication of the 2023 Annual Financial Report | 154 | Business Wire | Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform... ► Artikel lesen | |
| Mo | Mauna Kea Technologies Announces the Opening of a French Center of Excellence for the Use of Cellvizio in Lung Cancer Diagnostics | 129 | Business Wire | Cellvizio utilization continues to expand globally in established and emerging clinical indications
Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor... ► Artikel lesen | |
| 25.04. | Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales | 244 | Business Wire | Full Year 2023 Sales increased +42%1 to €10.5m €1.2m positive full-year operating income +47% growth in Q1 2024 in U.S. PPU volume Recent Telix strategic investment and restructured EIB... ► Artikel lesen | |
| 24.04. | Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank | 249 | Business Wire | Renewed EIB confidence in Mauna Kea extending support until 2029 Final maturities deferred 4 years to 2028 and 2029 Alignment of debt maturities with the Group's trajectory of profitability... ► Artikel lesen | |
| 04.04. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 182 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 02.04. | Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio to Identify and Treat Food Intolerance in Adults | 267 | Business Wire | Italy becomes the third country to launch a Cellvizio Center of Excellence following the Metrodora Institute in the U.S. and several other centers in Germany Another key milestone in a global... ► Artikel lesen | |
| 27.03. | Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio | 287 | Business Wire | Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, and V7... ► Artikel lesen | |
| 06.03. | Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio to Identify and Treat Food Intolerance in Adults | 232 | Business Wire | Cellvizio Food Intolerance Test (C-FIT) delivers real-time, in vivo visibility to accurately identify food intolerance in patients suffering from Irritable Bowel Syndrome (IBS) Metrodora will... ► Artikel lesen | |
| 05.03. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 185 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 07.02. | Mauna Kea Technologies Welcomes Benoit Chardon as Senior Advisor to Scale its Irritable Bowel Syndrome and Food Intolerance Business | 285 | Business Wire | Mr. Chardon is a recognized commercialization expert with a successful track record in new category creation in the health wellness industry
Regulatory News:
Mauna Kea Technologies (Euronext... ► Artikel lesen | |
| 05.02. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 358 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT)
Listing: Euronext Growth Paris
ISIN code:... ► Artikel lesen | |
| 01.02. | Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate | 291 | Business Wire | Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces... ► Artikel lesen | |
| 31.01. | MAUNA KEA TECHNOLOGIES: Half-Year Liquidity Contract Statement for H2 2023 with the Brokerage Firm Gilbert Dupont | 314 | Business Wire | Regulatory News:
Under the liquidity contract between the company MAUNA KEA TECHNOLOGIES (Paris:ALMKT) and the brokerage firm Gilbert Dupont, the following resources appeared on the liquidity account... ► Artikel lesen | |
| 25.01. | Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42%1 vs 2022 | 546 | Business Wire | PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy... ► Artikel lesen | |
| 08.01. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 296 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT)
Listing: Euronext Growth Paris
ISIN code:... ► Artikel lesen | |
| 05.12.23 | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 236 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 13.11.23 | Telix Pharmaceuticals Limited: Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery | 488 | PR Newswire | MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT,... ► Artikel lesen | |
| 13.11.23 | Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery | 528 | Business Wire | Builds on existing research collaboration for precision surgery in urology Telix Pharmaceuticals to acquire a ~19% stake in Mauna Kea Technologies through a €6 million equity investment
Regulatory... ► Artikel lesen | |
| 06.11.23 | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 333 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Listing: Euronext Growth Paris
ISIN code: FR0010609263, Ticker: ALMKT
Website:... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 5.595 |
| SUPER MICRO COMPUTER | 3.485 |
| BYD | 3.195 |
| BAYER | 3.120 |
| NEL | 2.647 |
| APPLE | 2.448 |
| NVIDIA | 2.353 |
| DEUTSCHE BANK | 2.249 |
| TUI | 2.204 |
| TESLA | 1.921 |
| MERCEDES-BENZ | 1.611 |
| PLUG POWER | 1.537 |
| AMAZON | 1.494 |
| VOLKSWAGEN | 1.442 |
| COMMERZBANK | 1.387 |
| RHEINMETALL | 1.279 |
| AIXTRON SE | 1.274 |
| RWE | 1.268 |
| NOVO NORDISK | 1.248 |
| DEUTSCHE LUFTHANSA | 1.215 |
| RENK GROUP | 1.192 |
| PAYPAL | 1.074 |
| BASF | 1.057 |
| DAIMLER TRUCK | 1.047 |
| SIEMENS ENERGY | 1.046 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
